指南与共识创伤与烧伤呼吸衰竭与机械通气重症综合管理与镇静镇痛

国际RAND/UCLA专家小组确定烧伤吸入性损伤的最佳诊断与管理

An international RAND/UCLA expert panel to determine the optimal diagnosis and management of burn inhalation injury.
PubMed 文献 · Crit Care · 2023-11-27
一句话结论烧伤吸入性损伤专家小组就诊断与管理达成多数共识:适宜包括初始插管使用≥8.0 mm气管导管、肺保护性通气、初始支气管镜灌洗、雾化肝素与沙丁胺醇;不适宜包括非保护性通气、高频振荡通气、预防性全身抗生素与糖皮质激素。

该研究采用改良Delphi法结合RAND/UCLA适宜性方法(RAM),由15名多学科专家(麻醉科、重症医学科和整形外科)对烧伤吸入性损伤(BII)诊断与管理选项的适宜性进行评分。最终调查包含140条陈述,分为病史与体格检查(20条)、检查(39条)、气道管理(5条)、全身毒性(23条)、有创机械通气(29条)和药物治疗(24条)。140条中74条评为适宜、40条不确定、26条不适宜;初始插管使用≥8.0 mm气管导管、肺保护性通气策略、初始支气管镜灌洗、重症BII系列支气管镜灌洗、中重度BII雾化肝素与沙丁胺醇、中度BII N-乙酰半胱氨酸评为适宜;非保护性通气策略、高频振荡通气、高频冲击通气、预防性全身抗生素和糖皮质激素评为不适宜。专家在6条陈述上存在分歧(DI≥1)并归为不确定。

要点

  • 初始插管使用内径≥8.0 mm气管导管评为适宜;内径<8.0 mm气管导管评为不确定(DI=1.19)。
  • 肺保护性通气策略评为适宜;非保护性通气策略、高频振荡通气、高频冲击通气评为不适宜。
  • 初始支气管镜灌洗和重症BII系列支气管镜灌洗评为适宜。
  • 中重度BII雾化肝素与沙丁胺醇、中度BII N-乙酰半胱氨酸评为适宜;轻度BII雾化5000IU肝素、N-乙酰半胱氨酸和沙丁胺醇评为不确定(DI分别为1.52、1.70、1.36)。
  • 预防性全身抗生素和糖皮质激素评为不适宜;柔性纤维支气管镜引导液体需求评为不确定(DI=1.52);气道压力释放通气模式评为不确定(DI=1.19)。

适用人群与场景

  • 涉及重大烧伤患者临床管理的麻醉科、重症医学科和整形外科专家小组所评估的烧伤吸入性损伤(BII)患者。

诊断标准与关键阈值

  • 采用改良Delphi法结合RAND/UCLA适宜性方法(RAM),专家在Likert量表上对陈述的适宜性评分,计算适宜性评分中位数和分歧指数(DI),将陈述分类为适宜、不确定或不适宜。

处置流程与药物剂量

  • 初始插管使用内径≥8.0 mm气管导管评为适宜。
  • 肺保护性通气策略评为适宜;非保护性通气策略、高频振荡通气、高频冲击通气评为不适宜。
  • 初始支气管镜灌洗评为适宜;重症BII系列支气管镜灌洗评为适宜。
  • 中重度BII雾化肝素和沙丁胺醇评为适宜;中度BII N-乙酰半胱氨酸评为适宜。
  • 预防性全身抗生素和糖皮质激素评为不适宜。

研究设计与关键结果

  • 15人多学科专家小组采用改良Delphi法结合RAM方法,最终调查包含140条陈述,分为病史与体格检查(20条)、检查(39条)、气道管理(5条)、全身毒性(23条)、有创机械通气(29条)和药物治疗(24条)。
  • 140条陈述中74条评为适宜、40条评为不确定、26条评为不适宜。
  • 初始插管使用≥8.0 mm气管导管、肺保护性通气策略、初始支气管镜灌洗、重症BII系列支气管镜灌洗、中重度BII雾化肝素和沙丁胺醇、中度BII N-乙酰半胱氨酸评为适宜。
  • 非保护性通气策略、高频振荡通气、高频冲击通气、预防性全身抗生素和糖皮质激素评为不适宜。
  • 6条陈述存在专家分歧(DI≥1)并归为不确定:柔性纤维支气管镜引导液体需求(DI=1.52)、内径<8.0 mm气管导管插管(DI=1.19)、气道压力释放通气模式(DI=1.19)、轻度BII雾化5000IU肝素(DI=1.52)、轻度BII雾化N-乙酰半胱氨酸(DI=1.70)、轻度BII雾化沙丁胺醇(DI=1.36)。

证据类型、等级与局限

  • 证据类型:改良Delphi研究结合RAND/UCLA适宜性方法(RAM)的专家意见。
  • 局限:原文报告不确定性存在于不同严重程度BII的最佳诊断和管理;未来研究应调查支气管镜分级BII的准确性、不同严重程度组支气管灌洗的价值以及雾化治疗在不同严重程度BII中的有效性。

对床旁实践的改变

  • 对于烧伤吸入性损伤患者,专家小组认为初始插管使用内径≥8.0 mm气管导管、肺保护性通气策略、初始支气管镜灌洗、重症BII系列支气管镜灌洗、中重度BII雾化肝素和沙丁胺醇、中度BII N-乙酰半胱氨酸为适宜。
  • 专家小组认为非保护性通气策略、高频振荡通气、高频冲击通气、预防性全身抗生素和糖皮质激素为不适宜。
  • 对于轻度BII雾化5000IU肝素、N-乙酰半胱氨酸和沙丁胺醇,以及柔性纤维支气管镜引导液体需求、内径<8.0 mm气管导管插管、气道压力释放通气模式,专家小组存在分歧,归为不确定。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Burn inhalation injury (BII) is a major cause of burn-related mortality and morbidity. Despite published practice guidelines, no consensus exists for the best strategies regarding diagnosis and management of BII. A modified DELPHI study using the RAND/UCLA (University of California, Los Angeles) Appropriateness Method (RAM) systematically analysed the opinions of an expert panel. Expert opinion was combined with available evidence to determine what constitutes appropriate and inappropriate judgement in the diagnosis and management of BII.

METHODS: A 15-person multidisciplinary panel comprised anaesthetists, intensivists and plastic surgeons involved in the clinical management of major burn patients adopted a modified Delphi approach using the RAM method. They rated the appropriateness of statements describing diagnostic and management options for BII on a Likert scale. A modified final survey comprising 140 statements was completed, subdivided into history and physical examination (20), investigations (39), airway management (5), systemic toxicity (23), invasive mechanical ventilation (29) and pharmacotherapy (24). Median appropriateness ratings and the disagreement index (DI) were calculated to classify statements as appropriate, uncertain, or inappropriate.

RESULTS: Of 140 statements, 74 were rated as appropriate, 40 as uncertain and 26 as inappropriate. Initial intubation with ≥ 8.0 mm endotracheal tubes, lung protective ventilatory strategies, initial bronchoscopic lavage, serial bronchoscopic lavage for severe BII, nebulised heparin and salbutamol administration for moderate-severe BII and N-acetylcysteine for moderate BII were rated appropriate. Non-protective ventilatory strategies, high-frequency oscillatory ventilation, high-frequency percussive ventilation, prophylactic systemic antibiotics and corticosteroids were rated inappropriate. Experts disagreed (DI ≥ 1) on six statements, classified uncertain: the use of flexible fiberoptic bronchoscopy to guide fluid requirements (DI = 1.52), intubation with endotracheal tubes of internal diameter < 8.0 mm (DI = 1.19), use of airway pressure release ventilation modality (DI = 1.19) and nebulised 5000IU heparin, N-acetylcysteine and salbutamol for mild BII (DI = 1.52, 1.70, 1.36, respectively).

CONCLUSIONS: Burns experts mostly agreed on appropriate and inappropriate diagnostic and management criteria of BII as in published guidance. Uncertainty exists as to the optimal diagnosis and management of differing grades of severity of BII. Future research should investigate the accuracy of bronchoscopic grading of BII, the value of bronchial lavage in differing severity groups and the effectiveness of nebulised therapies in different severities of BII.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Milton-Jones H, Soussi S, Davies R, et al. An international RAND/UCLA expert panel to determine the optimal diagnosis and management of burn inhalation injury. Crit Care. 2023. PMID: 38012797. doi:10.1186/s13054-023-04718-w

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。